These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4146776)

  • 1. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions.
    Yamada K; Shimamura T; Nakajima H
    Jpn J Pharmacol; 1973 Jun; 23(3):321-8. PubMed ID: 4146776
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on models used for the evaluation of antiarrhythmic drugs.
    Baum T; Eckfeld DK; Shropshire AT; Rowles G; Varner LL
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):149-70. PubMed ID: 5111320
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    Clin Pharmacol Ther; 1970; 11(4):460-80. PubMed ID: 4913865
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K; Oshima T; Koike H
    Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effects of various betaadrenergic blocking agents with known antiarrhythmic drugs on aconitine-arrhythmia produced by the cup method.
    Nakayama K; Oshima T; Kumakura S; Hashimoto K
    Eur J Pharmacol; 1971; 14(1):9-18. PubMed ID: 4396662
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiarrhythmic action of penbutolol].
    Boissier JR; Coutte R; Bertin MC; Giudicelli JF
    Therapie; 1974; 29(2):261-9. PubMed ID: 4152641
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 11. The antiarrhythmic properties of BL-3677A.
    Buyniski JP; Gardier RW
    J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
    Nakanishi M; Imamura H; Nakamura T
    Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):240-53. PubMed ID: 4403394
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
    Mest HJ; Thomsen P; Raap A
    Ann N Y Acad Sci; 1995 Jul; 763():620-33. PubMed ID: 7677382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological treatment of arrhythmia].
    Kuch J
    Pol Tyg Lek; 1983 Jan; 38(3):103-8. PubMed ID: 6135199
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs and the heart. IV. Antiarrhythmic agents.
    Opie LH
    Lancet; 1980 Apr; 1(8173):861-8. PubMed ID: 6103220
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiarrhythmic activity of 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Takagi K
    Jpn J Pharmacol; 1974 Aug; 24(4):589-9. PubMed ID: 4455968
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental anti-arrhythmic properties of melperone, a neuroleptic butyrophenone.
    Petersen EN
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):388-94. PubMed ID: 581034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiarrhythmic effect of blocking agent of beta-adrenergic receptors napriline].
    Gorodinskaia VIa
    Farmakol Toksikol; 1969; 32(1):43-7. PubMed ID: 5770314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.